NCT02797977 2023-06-22A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer SubjectsSierra Oncology LLC - a GSK companyPhase 1/2 Completed153 enrolled